Cargando…

Cellular therapies for the treatment and prevention of SARS-CoV-2 infection

Patients with blood disorders who are immune suppressed are at increased risk for infection with severe acute respiratory syndrome coronavirus 2. Sequelae of infection can include severe respiratory disease and/or prolonged duration of viral shedding. Cellular therapies may protect these vulnerable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conway, Susan R., Keller, Michael D., Bollard, Catherine M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Covid-19 and the Hematologist
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896869/ https://www.ncbi.nlm.nih.gov/pubmed/35240679 http://dx.doi.org/10.1182/blood.2021012249

Ejemplares similares

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Clinical features of thrombosis and bleeding in COVID-19
por: Thomas, Mari R., et al.
Publicado: (2022)

Vasculopathy in COVID-19
por: Flaumenhaft, Robert, et al.
Publicado: (2022)

COVID-19 in patients with hematologic malignancy
por: Langerbeins, Petra, et al.
Publicado: (2022)

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

Infections sévères à SARS-CoV-2
por: Taghboulit, N., et al.
Publicado: (2021)

Diaphragmatic myoclonus due to SARS-CoV-2 infection
por: Borroni, Barbara, et al.
Publicado: (2020)

Humoral and Cellular Immune Responses to SARS–CoV‐2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion
por: Simon, David, et al.
Publicado: (2021)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection
por: Bangi, Shifa, et al.
Publicado: (2020)

Important Steps to Control COVID-19/SARS-CoV-2 Infection
por: Chatterjee, Sudipto
Publicado: (2020)

First motor seizure as presenting symptom of SARS-CoV-2 infection
por: Fasano, Antonio, et al.
Publicado: (2020)

Air filtration and SARS-CoV-2
por: Nazarenko, Yevgen
Publicado: (2020)

Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature
por: Tepasse, Phil‐Robin, et al.
Publicado: (2020)

Corticosteroids and Other Treatments Administered to Children Tested for SARS-CoV-2 Infection in Emergency Departments
por: Freedman, Stephen B., et al.
Publicado: (2022)

Colitis as a Sole Presentation of SARS-CoV-2 Infection: Case Report
por: Jaijakul, Siraya
Publicado: (2020)

Portal Vein Thrombosis—a Rare Complication of SARS-CoV-2 Infection
por: Sharma, Neeraj, et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infections among hospitalized patients in southeastern Michigan
por: Fine, Sydney, et al.
Publicado: (2022)

A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
por: Kojima, N., et al.
Publicado: (2021)

Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis
por: Hada, Manila, et al.
Publicado: (2022)

Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
por: Pak, Theodore, et al.
Publicado: (2023)

The immunologic status of newborns born to SARS-CoV-2–infected mothers in Wuhan, China
por: Liu, Pin, et al.
Publicado: (2020)

SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome
por: Rosas-Salazar, Christian, et al.
Publicado: (2021)

Community socioeconomic deprivation and SARS-CoV-2 infection risk: findings from Portugal
por: Magalhães, João Paulo M, et al.
Publicado: (2021)

Posterior reversible encephalopathy syndrome: an atypical neurological manifestation of SARS-CoV-2 infection
por: Gasparotto, Michela, et al.
Publicado: (2022)

COVID-19 Vaccination Associated With Reduced Postoperative SARS-CoV-2 Infection and Morbidity
por: Prasad, Nikhil K., et al.
Publicado: (2022)

Genomic investigation to identify the source of SARS-CoV-2 infection among healthcare personnel
por: Sansom, Sarah, et al.
Publicado: (2022)

SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity
por: Rosichini, Marco, et al.
Publicado: (2023)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)

B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab
por: Stefanski, Ana‐Luisa, et al.
Publicado: (2022)

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective
por: Wong, Rebecca S. Y.
Publicado: (2020)

SARS-CoV-2, an Underestimated Pathogen of the Nervous System
por: Jakhmola, Shweta, et al.
Publicado: (2020)

SARS-CoV-2 vaccine-related neurological complications
por: Oonk, Nicol G. M., et al.
Publicado: (2022)

A Cluster of Aspergillosis Associated with SARS-CoV-2
por: VerLee, Kerrie, et al.
Publicado: (2021)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

Propofol and SARS-CoV-2 infection
por: Hirota, Kazuyoshi, et al.
Publicado: (2020)

Conjunctivitis as a Sentinel of SARS-CoV-2 Infection: a Need of Revision for Mild Symptoms
por: Panoutsopoulos, Alexios A.
Publicado: (2020)

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
por: Copaescu, Ana, et al.
Publicado: (2020)

Delayed presentation of postinfectious encephalitis associated with SARS-CoV-2 infection: a case report
por: Gunawardhana, Champika, et al.
Publicado: (2021)

Atrial fibrillation is related to higher mortality in COVID-19/SARS-CoV-2 pneumonia infection
por: Denegri, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gteavva6vekfjft6tqmeuqj28d